The DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.
Matrix metalloproteinase-7 protects against acute kidney injury by priming renal tubules for survival and regeneration
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
MMP7 promotes survival and regeneration in renal tubes, inducing protection against acute kidney injury.
“MMP7 promotes survival and regeneration in renal tubes, inducing protection against acute kidney injury.55”
From Canonical Wnt pathway and the LDL receptor superfamily in neuronal cholesterol homeostasis and function (2024) · cites this paper as [55]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Matrix metalloproteinases as modulators of inflammation and innate immunity
Parks, W. C., Wilson, C. L., & López-Boado, Y. S. (2004) · Nature Reviews Immunology · doi:10.1038/nri1418 · Cited by 1,929
Epidemiology of Acute Kidney Injury in Critically Ill Children and Young Adults
Kaddourah, A., Basu, R. K., Bagshaw, S. M., & Goldstein, S. L. (2017) · New England Journal of Medicine · doi:10.1056/nejmoa1611391 · Cited by 1,075
The Fas Signaling Pathway: More Than a Paradigm
Wajant, H. (2002) · Science · doi:10.1126/science.1071553 · Cited by 957
Flagged first, then by citations
Research works printed but not linked: 50
- Sharfuddin, 2011, Pathophysiology of ischemic acute kidney injury, Nat Rev Nephrol, 7, 189, 10.1038/nrneph.2011.16 · DOI
- Rewa, 2014, Acute kidney injury-epidemiology, outcomes and economics, Nat Rev Nephrol, 10, 193, 10.1038/nrneph.2013.282 · DOI · Paper page
- Singbartl, 2012, AKI in the ICU: definition, epidemiology, risk stratification, and outcomes, Kidney Int, 81, 819, 10.1038/ki.2011.339 · DOI
- Bagshaw, 2016, Acute kidney injury: Timing of renal replacement therapy in AKI, Nat Rev Nephrol, 12, 445, 10.1038/nrneph.2016.92 · DOI
- Moledina, 2018, Phenotyping of acute kidney injury: beyond serum creatinine, Semin Nephrol, 38, 3, 10.1016/j.semnephrol.2017.09.002 · DOI
- Bulluck, 2018, Neutrophil gelatinase-associated lipocalin prior to cardiac surgery predicts acute kidney injury and mortality, Heart, 104, 313, 10.1136/heartjnl-2017-311760 · DOI
- Medic, 2016, Evaluation of novel biomarkers of acute kidney injury: the possibilities and limitations, Curr Med Chem, 23, 1981, 10.2174/0929867323666160210130256 · DOI
- Ho, 2015, Urinary, plasma, and serum biomarkers' utility for predicting acute kidney injury associated with cardiac surgery in adults: a meta-analysis, Am J Kidney Dis, 66, 993, 10.1053/j.ajkd.2015.06.018 · DOI
- Adler, 2018, TIMP-2/IGFBP7 predicts acute kidney injury in out-of-hospital cardiac arrest survivors, Crit Care, 22, 126, 10.1186/s13054-018-2042-9 · DOI
- Kashani, 2013, Discovery and validation of cell cycle arrest biomarkers in human acute kidney injury, Crit Care, 17, R25, 10.1186/cc12503 · DOI
- Yang, 2017, Urinary matrix metalloproteinase-7 predicts severe AKI and poor outcomes after cardiac surgery, J Am Soc Nephrol, 28, 3373, 10.1681/ASN.2017020142 · DOI
- Tan, 2012, Matrix metalloproteinases in kidney homeostasis and diseases, Am J Physiol Renal Physiol, 302, F1351, 10.1152/ajprenal.00037.2012 · DOI
- Ke, 2017, Matrix metalloproteinases-7 and kidney fibrosis, Front Physiol, 8, 21
- Zhou, 2017, Matrix metalloproteinase-7 is a urinary biomarker and pathogenic mediator of kidney fibrosis, J Am Soc Nephrol, 28, 598, 10.1681/ASN.2016030354 · DOI
- Grindel, 2014, Matrilysin/matrix metalloproteinase-7(MMP7) cleavage of perlecan/HSPG2 creates a molecular switch to alter prostate cancer cell behavior, Matrix Biol, 36, 64, 10.1016/j.matbio.2014.04.005 · DOI
- He, 2012, Matrix metalloproteinase-7 as a surrogate marker predicts renal Wnt/beta-catenin activity in CKD, J Am Soc Nephrol, 23, 294, 10.1681/ASN.2011050490 · DOI
- Rims, 2014, Matrilysin (MMP-7) catalytic activity regulates beta-catenin localization and signaling activation in lung epithelial cells, Exp Lung Res, 40, 126, 10.3109/01902148.2014.890681 · DOI
- Surendran, 2004, Matrilysin (MMP-7) expression in renal tubular damage: association with Wnt4, Kidney Int, 65, 2212, 10.1111/j.1523-1755.2004.00641.x · DOI
- Duarte, 2015, Matrix metalloproteinases in liver injury, repair and fibrosis, Matrix Biol, 44–46, 147, 10.1016/j.matbio.2015.01.004 · DOI
- Basu, 2015, Loss of matrix metalloproteinase-8 is associated with worsened recovery after ischemic kidney injury, Ren Fail, 37, 469, 10.3109/0886022X.2014.996842 · DOI
- Kaneko, 2012, Role of matrix metalloproteinase-2 in recovery after tubular damage in acute kidney injury in mice, Nephron Exp Nephrol, 122, 23, 10.1159/000346569 · DOI
- Lee, 2011, MMP-9 gene deletion mitigates microvascular loss in a model of ischemic acute kidney injury, Am J Physiol Renal Physiol, 301, F101, 10.1152/ajprenal.00445.2010 · DOI
- Kunugi, 2011, Inhibition of matrix metalloproteinases reduces ischemia-reperfusion acute kidney injury, Lab Invest, 91, 170, 10.1038/labinvest.2010.174 · DOI
- Ho, 2016, Elevated urinary matrix metalloproteinase-7 detects underlying renal allograft inflammation and injury, Transplantation, 100, 648, 10.1097/TP.0000000000000867 · DOI
- Afkarian, 2015, Urine matrix metalloproteinase-7 and risk of kidney disease progression and mortality in type 2 diabetes, J Diabetes Complications, 29, 1024, 10.1016/j.jdiacomp.2015.08.024 · DOI
- Ramesh, 2014, Mouse models and methods for studying human disease, acute kidney injury (AKI), Methods Mol Biol, 1194, 421, 10.1007/978-1-4939-1215-5_24 · DOI
- Wei, 2012, Mouse model of ischemic acute kidney injury: technical notes and tricks, Am J Physiol Renal Physiol, 303, F1487, 10.1152/ajprenal.00352.2012 · DOI
- Mishra, 2005, Neutrophil gelatinase-associated lipocalin (NGAL) as a biomarker for acute renal injury after cardiac surgery, Lancet, 365, 1231, 10.1016/S0140-6736(05)74811-X · DOI · Paper page
- Waring, 1999, Cell death induced by the Fas/Fas ligand pathway and its role in pathology, Immunol Cell Biol, 77, 312, 10.1046/j.1440-1711.1999.00837.x · DOI
- Elmore, 2007, Apoptosis: a review of programmed cell death, Toxicol Pathol, 35, 495, 10.1080/01926230701320337 · DOI · Paper page
- Zhou, 2012, Tubule-specific ablation of endogenous beta-catenin aggravates acute kidney injury in mice, Kidney Int, 82, 537, 10.1038/ki.2012.173 · DOI
- Simenc, 2012, Staurosporine induces apoptosis and necroptosis in cultured rat astrocytes, Drug Chem Toxicol, 35, 399, 10.3109/01480545.2011.633087 · DOI
- Bonventre, 2011, Cellular pathophysiology of ischemic acute kidney injury, J Clin Invest, 121, 4210, 10.1172/JCI45161 · DOI
- Kuncewitch, 2015, WNT agonist decreases tissue damage and improves renal function after ischemia-reperfusion, Shock, 43, 268, 10.1097/SHK.0000000000000293 · DOI
- Chang-Panesso, 2017, Cellular plasticity in kidney injury and repair, Nat Rev Nephrol, 13, 39, 10.1038/nrneph.2016.169 · DOI
- Basile, 2012, Pathophysiology of acute kidney injury, Compr Physiol, 2, 1303, 10.1002/j.2040-4603.2012.tb00431.x · DOI
- Green, 2004, The pathophysiology of mitochondrial cell death, Science, 305, 626, 10.1126/science.1099320 · DOI
- Strand, 2004, Cleavage of CD95 by matrix metalloproteinase-7 induces apoptosis resistance in tumour cells, Oncogene, 23, 3732, 10.1038/sj.onc.1207387 · DOI
- Wang, 2006, Matrix metalloproteinase-7 increases resistance to Fas-mediated apoptosis and is a poor prognostic factor of patients with colorectal carcinoma, Carcinogenesis, 27, 1113, 10.1093/carcin/bgi351 · DOI
- Mitsiades, 2001, Matrix metalloproteinase-7-mediated cleavage of Fas ligand protects tumor cells from chemotherapeutic drug cytotoxicity, Cancer Res, 61, 577
- Powell, 1999, The metalloproteinase matrilysin proteolytically generates active soluble Fas ligand and potentiates epithelial cell apoptosis, Curr Biol, 9, 1441, 10.1016/S0960-9822(00)80113-X · DOI
- Zhou, 2013, Kidney tubular beta-catenin signaling controls interstitial fibroblast fate via epithelial-mesenchymal communication, Sci Rep, 3, 1878, 10.1038/srep01878 · DOI
- Vandenbroucke, 2014, Pro-inflammatory effects of matrix metalloproteinase 7 in acute inflammation, Mucosal Immunol, 7, 579, 10.1038/mi.2013.76 · DOI
- Mande, 2018, Fas ligand promotes an inducible TLR-dependent model of cutaneous lupus-like inflammation, J Clin Invest, 128, 2966, 10.1172/JCI98219 · DOI
- Bien, 2015, Fas/FasL pathway participates in regulation of antiviral and inflammatory response during mousepox infection of lungs, Mediators Inflamm, 2015, 10.1155/2015/281613 · DOI
- Keppler, 2007, Plasma creatinine determination in mice and rats: an enzymatic method compares favorably with a high-performance liquid chromatography assay, Kidney Int, 71, 74, 10.1038/sj.ki.5001988 · DOI
- Lazzeri, 2018, Endocycle-related tubular cell hypertrophy and progenitor proliferation recover renal function after acute kidney injury, Nat Commun, 9, 1344, 10.1038/s41467-018-03753-4 · DOI
- Zhou, 2016, Wnt/beta-catenin signaling in kidney injury and repair: a double-edged sword, Lab Invest, 96, 156, 10.1038/labinvest.2015.153 · DOI
- Zhou, 2013, Activation of hepatocyte growth factor receptor, c-met, in renal tubules is required for renoprotection after acute kidney injury, Kidney Int, 84, 509, 10.1038/ki.2013.102 · DOI
- Fu, 2017, Tenascin-C is a major component of the fibrogenic niche in kidney fibrosis, J Am Soc Nephrol, 28, 785, 10.1681/ASN.2016020165 · DOI
Cited by
Sorted by citations
Borrell-Pages, M., Luquero, A., Vilahur, G., Padró, T., & Badimon, L. (2024) · Cardiovascular Research · doi:10.1093/cvr/cvad159 · Cited by 10
Metadata
- Authors
- Fu, H., Zhou, D., Zhu, H., Liao, J., Lin, L., Hong, X., Hou, F. F., & Liu, Y.
- Venue
- Kidney International
- Publisher
- Elsevier BV
- Published
- 2019-05
- Volume
- 95
- Issue
- 5
- Pages
- 1167-1180
- ISSN
- 0085-2538
- PMC
- PMC6478554
- Cited by
- 65
- References
- 3
- Language
- en
- Licence
- Funders
- National Institutes of Health (DK106049, DK064005)
- National Natural Science Foundation of China (81770715, 81770737, 81521003)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review